House Approves Bill Authorizing Cannabis Research for Veterans

A key congressional committee last week approved a bill that would authorize federal research into the therapeutic applications of cannabis for military veterans.

The committee approved previous versions of the bill last year and in 2018, but the legislation has yet to be passed by the full Congress and signed into law.

“Our veterans are no strangers to confronting challenges, and that’s why Congress needs to explore alternative treatment options,” Rep.

In addition, the National Institute on Drug Abuse has advised Congress that there is “substantial evidence” that cannabis has medicinal value as a treatment for chronic pain and urged lawmakers to fund research into the potential risks and benefits of medical marijuana.

Officials with the VA opposed the legislation at last week’s hearing, citing difficulties conducting research under the terms of the bill.

“We simply must equip VA and its healthcare providers with scientific guidance about the potential impacts, benefits and/or dangers of cannabis used to treat chronic pain and PTSD,” Takano said ahead of the vote.

With scientific data lacking, many veterans affected by the continuing challenges of military service self-medicate with cannabis to help ease conditions including chronic pain, insomnia, and PTSD.

Andy Meiars, a founder of the Battle Brothers Foundation , tells Cannabis Now that the nonprofit organization is helping to fund cannabis research in partnership with the California licensed, veteran-owned brand Helmand Valley Growers Company, which donates 100% of all profits to support studies investigating the therapeutic possibilities of cannabis for veterans.

Meiars says that the research team will soon be enrolling veterans for the study and sees Veterans Day as a fitting opportunity to explain the importance of access to cannabis for veterans.

“We’re trying to make it possible for them to have access not only to cannabis, but for the better quality of life that they fought for.

…Read the full story